Showing results (11-20 of 33) with videos related to
Sort By:
Pageof 4
British Journal of Haematology|September 1, 1999
Therapeutic monitoring of von Willebrand disease: interest and limits of a platelet function analyser at high shear ratesE Fressinaud, A Veyradier, M Sigaud, et al.La Revue De Medecine Interne|November 19, 2011
[Clopidogrel induced thrombotic thrombocytopenic purpura]L Karkowski, M Wolf, J Lescampf, et al.La Revue De Medecine Interne|December 19, 2015
[Telemedicine in thrombotic microangiopathies: A way forward in rare diseases requiring emergency care]P Coppo, E Corre, E Rondeau, et al.Haemophilia : the Official Journal of the World Federation of Hemophilia|March 5, 2011
Validation of the first commercial ELISA for type 2N von Willebrand's disease diagnosisA Veyradier, C Caron, C Ternisien, et al.Journal of Thrombosis and Haemostasis : JTH|August 18, 2009
IgG subclass distribution of anti-ADAMTS13 antibodies in patients with acquired thrombotic thrombocytopenic purpuraS Ferrari, G C Mudde, M Rieger, et al.Blood|March 7, 1998
Screening for von Willebrand disease with a new analyzer using high shear stress: a study of 60 casesE Fressinaud, A Veyradier, F Truchaud, et al.Archives De Pediatrie : Organe Officiel De La Societe Francaise De Pediatrie|September 29, 2015
[Mild hemophilia A fortuitously discovered during Henoch-Schönlein purpura]B Joly, R d'Oiron, C Desconclois, et al.Journal of Thrombosis and Haemostasis : JTH|March 11, 2004
Ten candidate ADAMTS13 mutations in six French families with congenital thrombotic thrombocytopenic purpura (Upshaw-Schulman syndrome)A Veyradier, J-M Lavergne, A-S Ribba, et al.Thrombosis and Haemostasis|August 24, 1999
New assay for measuring binding of platelet glycoprotein IIb/IIIa to unpurified von Willebrand factorA Veyradier, A L Jumilly, A S Ribba, et al.Circulation|November 15, 2000
Improvement of von Willebrand factor proteolysis after prostacyclin infusion in severe pulmonary arterial hypertensionA Veyradier, T Nishikubo, M Humbert, et al.Pageof 4